Collaborative Research on Quality Control Mechanism of Newly Synthesized Proteins

新合成蛋白质质量控​​制机制合作研究

基本信息

  • 批准号:
    11694094
  • 负责人:
  • 金额:
    $ 3.2万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

We investigated the quality control mechanism of newly synthesized proteins in the endoplasmic reticulum (ER) by using under-γ-carboxylated protein C (uc-PC), antithrombin (AT) ΔGlu313 and Pro429stop mutants and cogTg (thyroglobulin Leu2266Pro mutant) as models of misfolded proteins. [Results] 1. Analyses of the effects of high level co-expression of molecular chaperones (BiP, ERp72, ER94 or PDI) in CHO cells on the secretion and degradation of misfolded proteins. 1) In cells expressing a high level of BiP, PDI or ERp72, even wild-type PC was degraded without secretion. 2) Degradation of uc-PC was enhanced with co-expression of ERp72. In contrast, it was rather suppressed in cases of BiP and PDI.3) Wild-type AT was also partially degraded in CHO cells co-expressing BiP or ERp72. 4) Degradation of ΔGlu313 AT was enhanced with co-expression of BiP or ERp72, while that of Pro429stop AT was enhanced only with ERp72. 5) CogTg co-expressed with BiP or ER94 was mostly retained and accumulated in the ER.Thus, the effects of over-expression of molecular chaperones were quite variable among proteins.2. Mannose trimming of N-linked oligosaccharide(s) is proposed to be important for quality control of newly synthesized proteins and formation of Man8B form is critical for targeting misfolded glycoproteins to the degradation pathway. We examined the effects of a high level of co-expression of mannosidase I (whose action generates a Man8B form) or Edem (mannosidase I homologue) on the degradations of ΔGlu313 AT and Pro429stop AT.The result showed that degradations of both AT mutants were enhanced in CHO cells co-expressing a high level of Edem. This result strongly suggests that Edem is a key factor which introduces misfolded glycoproteins into the degradation pathway.
以γ-羧基化不足的蛋白C(uc-PC)、抗凝血酶(AT)Δ Glu 313和Pro429 stop突变体以及甲状腺球蛋白Leu 2266 Pro突变体(cogTg)为错误折叠蛋白质模型,探讨内质网(ER)中新合成蛋白质的质量控制机制。[结果] 1.分析CHO细胞中高水平共表达分子伴侣(BiP、ERp 72、ER 94或PDI)对错误折叠蛋白质的分泌和降解的影响。1)在表达高水平BiP、PDI或ERp 72的细胞中,甚至野生型PC也被降解而不分泌。2)ERp 72的共表达增强了uc-PC的降解。相比之下,在BiP和PDI的情况下,它受到相当大的抑制。3)野生型AT在共表达BiP或ERp 72的CHO细胞中也被部分降解。4)BiP或ERp 72共表达可增强Δ Glu 313 AT的降解,而只有ERp 72可增强Pro429 stop AT的降解。5)与BiP或ER 94共表达的CogTg大部分保留并积累在ER中,因此,分子伴侣过表达的影响在蛋白质之间存在很大差异.提出N-连接寡糖的甘露糖修剪对于新合成蛋白质的质量控制是重要的,并且Man 8B形式的形成对于将错误折叠的糖蛋白靶向至降解途径是关键的。我们检测了高水平共表达甘露糖苷酶I(其作用产生Man 8B形式)或Edem(甘露糖苷酶I同源物)对Δ Glu 313 AT和Pro429 stop AT的降解的影响。结果表明,在共表达高水平Edem的CHO细胞中,两种AT突变体的降解增强。这一结果强烈表明Edem是将错误折叠的糖蛋白引入降解途径的关键因素。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takehiko Koide.: "Proteins are also quality-controlled in the cells. In "Wonder of Proteolysis"."Kubapro Co., Tokyo(in press). (2001)
Takehiko Koide.:“蛋白质在细胞中也受到质量控制。在“蛋白水解的奇迹”中。”Kubapro Co.,东京(正在印刷中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fuminori Tokunaga.: "Frontier of mechanism of endoplasmic reticulum-associated degradation."Jikken Igaku. 19(2). 263-270
Fuminori Tokunaga.:“内质网相关降解机制的前沿。”Jikken Igaku。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fuminori Tokunaga: "Secretion, γ-carboxylation, and endoplasmic reticulum-associated degradation of chimeras with mutually exchanged Gla domain……."Thrombosis Research. 99・5. 511-521 (2000)
Fuminori Tokunaga:“具有相互交换的 Gla 结构域的嵌合体的分泌、γ-羧化和内质网相关降解......”血栓形成研究 99・5(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sadao Wakabayashi: "Intracellular degradation of histidine-rich glycoprotein mutants : Tokushima-1 and 2 mutants are degraded by the different.……"Journal of Biochemistry. 128・2. 201-206 (2000)
Sadao Wakabayashi:“富含组氨酸的糖蛋白突变体的细胞内降解:Tokushima-1 和 2 突变体被不同的降解......”《生物化学杂志》128・2(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
徳永文稔: "小胞体関連分解機構の最前線"実験医学. 19・2. 263-270 (2000)
德永文志:“内质网相关降解机制的前沿”实验医学19・2(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KOIDE Takehiko其他文献

KOIDE Takehiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KOIDE Takehiko', 18)}}的其他基金

Studies on structural characteristics and physiological function of a novel membrane-bound proteasome
新型膜结合蛋白酶体的结构特征和生理功能研究
  • 批准号:
    14380297
  • 财政年份:
    2002
  • 资助金额:
    $ 3.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of Structure and Function of Proteasome Derived from Rat Liver Microsome
大鼠肝微粒体蛋白酶体的结构与功能分析
  • 批准号:
    11480170
  • 财政年份:
    1999
  • 资助金额:
    $ 3.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analyzes of Molecular Mechanism of Protein Secretion Using Abnormal Protein C as a Model Protein
以异常蛋白C为模型蛋白分析蛋白分泌的分子机制
  • 批准号:
    05454624
  • 财政年份:
    1993
  • 资助金额:
    $ 3.2万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Molecular Genetic Studies of Thrombosis
血栓形成的分子遗传学研究
  • 批准号:
    01480298
  • 财政年份:
    1989
  • 资助金额:
    $ 3.2万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Molecular Biological and Biochemical Studies on the Control Mechanism of Blood Coagulation and Fibrinolysis
凝血和纤溶控制机制的分子生物学和生化研究
  • 批准号:
    61480459
  • 财政年份:
    1986
  • 资助金额:
    $ 3.2万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

The role for ER associated degradation (ERAD) in T cell homeostasis and memory
ER 相关降解 (ERAD) 在 T 细胞稳态和记忆中的作用
  • 批准号:
    10582915
  • 财政年份:
    2023
  • 资助金额:
    $ 3.2万
  • 项目类别:
Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation
ERα相关降解对节律性 m6A RNA 修饰的调节
  • 批准号:
    10297978
  • 财政年份:
    2021
  • 资助金额:
    $ 3.2万
  • 项目类别:
Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation
ERα相关降解对节律性 m6A RNA 修饰的调节
  • 批准号:
    10615181
  • 财政年份:
    2021
  • 资助金额:
    $ 3.2万
  • 项目类别:
Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation
ERα相关降解对节律性 m6A RNA 修饰的调节
  • 批准号:
    10454294
  • 财政年份:
    2021
  • 资助金额:
    $ 3.2万
  • 项目类别:
The role of ER associated degradation (ERAD) in hematopoietic stem cells
ER相关降解(ERAD)在造血干细胞中的作用
  • 批准号:
    10187650
  • 财政年份:
    2020
  • 资助金额:
    $ 3.2万
  • 项目类别:
The role of ER associated degradation (ERAD) in hematopoietic stem cells
ER相关降解(ERAD)在造血干细胞中的作用
  • 批准号:
    10454963
  • 财政年份:
    2020
  • 资助金额:
    $ 3.2万
  • 项目类别:
The role of ER associated degradation (ERAD) in hematopoietic stem cells
ER相关降解(ERAD)在造血干细胞中的作用
  • 批准号:
    10649697
  • 财政年份:
    2020
  • 资助金额:
    $ 3.2万
  • 项目类别:
Examining Mechanism and Physiological Significance of HMG CoA Reductase ER-Associated Degradation
检查 HMG CoA 还原酶 ER 相关降解的机制和生理意义
  • 批准号:
    10396981
  • 财政年份:
    2019
  • 资助金额:
    $ 3.2万
  • 项目类别:
Examining Mechanism and Physiological Significance of HMG CoA Reductase ER-Associated Degradation
检查 HMG CoA 还原酶 ER 相关降解的机制和生理意义
  • 批准号:
    9978121
  • 财政年份:
    2019
  • 资助金额:
    $ 3.2万
  • 项目类别:
Defining the Central Role of ER-Associated Degradation (ERAD) in Neuroendocrine Cells
定义 ER 相关降解 (ERAD) 在神经内分泌细胞中的核心作用
  • 批准号:
    9789260
  • 财政年份:
    2018
  • 资助金额:
    $ 3.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了